ResultsIQ

ResultsIQ › Latest results › Acutaas Chemicals Limited

Acutaas Chemicals Limited Q1 FY27 earnings call summary

NSE: ACUTAAS · BSE: 543349

Earnings call of 24 Jul 2026, summarised by AI from the filing.

Acutaas Chemicals Q1 FY27 revenue ₹329.7 cr, up 59.1% Y-o-Y; management guides 25% revenue growth for FY27 with stable margins.

Key takeaways

  1. Revenue Q1 FY27 revenue ₹329.7 cr, growth of 59.1% Y-o-Y.
  2. Guidance Management confident of 25% revenue growth for FY27 with stable margins.
  3. Battery chemicals Trial run completed and commercial supply started; rapid ramp-up expected over coming quarters.
  4. CDMO Management confident to hit ₹1,000 cr CDMO revenue and beat the target.
  5. Risk Geopolitical tensions in the Gulf persist, requiring efforts to secure raw material availability.

Original filing on BSE

Acutaas Chemicals Limited Q1 FY27 results

As filed: Revenue ₹330 cr (+59% year on year), EBITDA ₹113 cr (+122% year on year), PAT ₹75.0 cr (+70% year on year), EBITDA margin 34.3% (+966 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹422 cr, EBITDA ₹181 cr, PAT ₹137 cr, EBITDA margin 43.0%. Not scored. No result for the same quarter last year. Share price after the results: +25.2% in 29 days (Nifty 500: −0.9%).
  • Q3 FY26: Revenue ₹391 cr, EBITDA ₹154 cr, PAT ₹112 cr, EBITDA margin 39.5%. Not scored. No result for the same quarter last year. Share price after the results: +30.9% in 30 days (Nifty 500: +1.5%).
  • Q2 FY26: Revenue ₹305 cr, EBITDA ₹97.0 cr, PAT ₹73.0 cr, EBITDA margin 31.8%. Not scored. No result for the same quarter last year. Share price after the results: +10.2% in 28 days (Nifty 500: +1.2%).
  • Q1 FY26: Revenue ₹206 cr, EBITDA ₹51.0 cr, PAT ₹45.0 cr, EBITDA margin 24.8%. Not scored. No result for the same quarter last year. Share price after the results: +20.5% in 30 days (Nifty 500: −2.4%).

Past price moves after results do not indicate future moves. Not a recommendation.

Acutaas Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.